Abstract
Patients with primary ovarian insufficiency (POI) are classically oriented to egg donation due to the lack of currently available efficient treatments. In response to this shortcoming, modified natural in vitro fertilization cycle (mnIVF) combined with dehydroepiandrostenedione (DHEA) neoadjuvant treatment is an original therapeutic tool at our disposal. A 33-year-old patient with idiopathic POI was prescribed DHEA neoadjuvant treatment. She rapidly recovered her menstrual cycle and after 3 months of DHEA, basal follicle-stimulating hormone has decreased drastically. Then, a mnIVF was performed. The patient got pregnant and gave birth to a healthy girl. She became pregnant a second time under DHEA only. Coupled with DHEA neoadjuvant treatment, a mnIVF could be a useful therapeutic tool for extremely poor prognosis patients with POI.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
